Education of Providers on Prescribing Best Practices
1 other identifier
interventional
369
1 country
1
Brief Summary
This study aims to evaluate the impact of spaced education, delivered via a smartphone application, on provider prescribing patterns.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2018
CompletedFirst Posted
Study publicly available on registry
December 11, 2018
CompletedStudy Start
First participant enrolled
December 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2020
CompletedOctober 14, 2020
October 1, 2020
6 months
December 7, 2018
October 13, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Median morphine milligram equivalents (MME) per opioid prescription
By extracting prescribing data for opioids from the electronic health records
8 months
Percentage of orders for balanced intravenous (IV) fluid solutions (i.e. not normal saline)
By extracting prescribing data for intravenous fluids from the electronic health records
8 months
Secondary Outcomes (9)
Chloride levels in patients receiving intravenous fluid orders from a provider enrolled in the study
8 months
Potassium levels in patients receiving intravenous fluid orders from a provider enrolled in the study
8 months
Major Adverse Kidney Events by 30 days (MAKE 30) in patients receiving intravenous fluid orders from a provider enrolled in the study
30 days
Length of stay for patients receiving an intravenous fluid order or an opioid prescription from a provider enrolled in the study.
8 months
Length of stay in the intensive care unit (ICU) for patients receiving an intravenous fluid order or an opioid prescription from a provider enrolled in the study
8 months
- +4 more secondary outcomes
Study Arms (2)
Opioid module first then fluid
ACTIVE COMPARATORThe providers in this arm will first receive daily information and questions related to opioid use for eight weeks and then daily information and questions related to intravenous fluid prescribing for five weeks.
Fluid module first then opioid
ACTIVE COMPARATORThe providers in this arm will first receive daily information and questions related to intravenous fluid prescribing for five weeks and then daily information and questions related to opioid use for eight weeks.
Interventions
Text Messaging or Email system
Eligibility Criteria
You may qualify if:
- All inpatient prescribing providers
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Related Publications (2)
McEvoy MD, Dear ML, Buie R, Edwards DA, Barrett TW, Allen B, Robertson AC, Fowler LC, Hennessy C, Miller BM, Garvey KV, Bland RP 3rd, Fleming GM, Moore D, Rice TW, Bernard GR, Lindsell CJ; Vanderbilt Learning Healthcare System Platform Investigators and the Vanderbilt Committee on Opioid Monitoring and Stewardship. Effect of Smartphone App-Based Education on Clinician Prescribing Habits in a Learning Health Care System: A Randomized Cluster Crossover Trial. JAMA Netw Open. 2022 Jul 1;5(7):e2223099. doi: 10.1001/jamanetworkopen.2022.23099.
PMID: 35881398DERIVEDMcEvoy MD, Dear ML, Buie R, Fowler LC, Miller B, Fleming GM, Moore D, Rice TW, Bernard GR, Lindsell CJ; Vanderbilt Learning Healthcare System Investigators. Embedding Learning in a Learning Health Care System to Improve Clinical Practice. Acad Med. 2021 Sep 1;96(9):1311-1314. doi: 10.1097/ACM.0000000000003969.
PMID: 33570841DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew McEvoy, MD
Vanderbilt University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Anesthesiology
Study Record Dates
First Submitted
December 7, 2018
First Posted
December 11, 2018
Study Start
December 30, 2019
Primary Completion
June 15, 2020
Study Completion
June 15, 2020
Last Updated
October 14, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- 3 months after publication for 5 years
- Access Criteria
- Researchers who provide a methodologically sound proposal that has been approved by the Vanderbilt Institutional Review Board and the study executive committee.
Data dictionaries and individual participant data that underlie the results reported after de-identification will be available.